Since 20 μM doses of rapalogs promoted pseudovirus infection mediated by SARS-CoV-2 spike, we tested how pretreatment of A549-ACE2 cells with varying amounts of everolimus would affect infection by replication-competent SARS-CoV-2. The gene discussed is ACE2; the disease is infection.